Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Ryu

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Liver Research|February 17, 2025
New insights in the pathogenesis of alcohol-related liver disease: The metabolic, immunologic, and neurologic pathways<sup>☆</sup>Tom Ryu, Kyurae Kim, Sung Eun Choi, et al.
International Journal of Molecular Sciences|October 29, 2025
Class-Specific Effects of ARBs Versus ACE Inhibitors on Survival and Cardiovascular Outcomes in MASLDTom Ryu, Yeon Joo Seo, Jaejun Lee, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|May 28, 2025
Protective effects of Ginkgo biloba supplementation on clinical outcomes in metabolic dysfunction-associated steatotic liver diseaseTom Ryu, Beom Sun Chung, Jaejun Lee, et al.
Scientific Reports|March 14, 2025
Multivitamin supplementation and its impact in metabolic dysfunction-associated steatotic liver diseaseTom Ryu, Seung Yun Chae, Jaejun Lee, et al.
Therapeutic Advances in Gastroenterology|April 28, 2025
A comprehensive analysis of the impact of smoking on adverse clinical outcomes of steatotic liver diseasesKeungmo Yang, Jaejun Lee, Ji Won Han, et al.
Translational Gastroenterology and Hepatology|November 11, 2025
The prognostic impact of statin exposure in metabolic dysfunction-associated steatotic liver disease: a cohort studyKeungmo Yang, Seung Yun Chae, Jaejun Lee, et al.
Journal of Neurogastroenterology and Motility|September 29, 2020
Esophageal Involvement and Determinants of Perception of Esophageal Symptoms Among South Koreans With Systemic SclerosisJoon Seong Lee, Hyun-Sook Kim, Jung Rock Moon, et al.
Frontiers in Medicine|July 8, 2026
Divergent risk profiles for cause-specific mortality in MASLD and MetALD: a nationwide population-based studyHyuk Kim, Jeong-Ju Yoo, Young Chang, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 28, 2025
Glucosamine supplementation attenuates progression of metabolic dysfunction-associated steatotic liver disease and related comorbiditiesTom Ryu, Young Chang, Jeong-Ju Yoo, et al.
Clinical and Molecular Hepatology|January 9, 2025
Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis CTom Ryu, Young Chang, Soung Won Jeong, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Liver Research|February 17, 2025
New insights in the pathogenesis of alcohol-related liver disease: The metabolic, immunologic, and neurologic pathways<sup>☆</sup>Tom Ryu, Kyurae Kim, Sung Eun Choi, et al.
International Journal of Molecular Sciences|October 29, 2025
Class-Specific Effects of ARBs Versus ACE Inhibitors on Survival and Cardiovascular Outcomes in MASLDTom Ryu, Yeon Joo Seo, Jaejun Lee, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|May 28, 2025
Protective effects of Ginkgo biloba supplementation on clinical outcomes in metabolic dysfunction-associated steatotic liver diseaseTom Ryu, Beom Sun Chung, Jaejun Lee, et al.
Scientific Reports|March 14, 2025
Multivitamin supplementation and its impact in metabolic dysfunction-associated steatotic liver diseaseTom Ryu, Seung Yun Chae, Jaejun Lee, et al.
Therapeutic Advances in Gastroenterology|April 28, 2025
A comprehensive analysis of the impact of smoking on adverse clinical outcomes of steatotic liver diseasesKeungmo Yang, Jaejun Lee, Ji Won Han, et al.
Translational Gastroenterology and Hepatology|November 11, 2025
The prognostic impact of statin exposure in metabolic dysfunction-associated steatotic liver disease: a cohort studyKeungmo Yang, Seung Yun Chae, Jaejun Lee, et al.
Journal of Neurogastroenterology and Motility|September 29, 2020
Esophageal Involvement and Determinants of Perception of Esophageal Symptoms Among South Koreans With Systemic SclerosisJoon Seong Lee, Hyun-Sook Kim, Jung Rock Moon, et al.
Frontiers in Medicine|July 8, 2026
Divergent risk profiles for cause-specific mortality in MASLD and MetALD: a nationwide population-based studyHyuk Kim, Jeong-Ju Yoo, Young Chang, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 28, 2025
Glucosamine supplementation attenuates progression of metabolic dysfunction-associated steatotic liver disease and related comorbiditiesTom Ryu, Young Chang, Jeong-Ju Yoo, et al.
Clinical and Molecular Hepatology|January 9, 2025
Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis CTom Ryu, Young Chang, Soung Won Jeong, et al.
Pageof 4